Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Edmonson JH, Krook JE, Hilton JF, Malkasian GD, Everson LK, Jefferies JA, Mailliard JA

Publication

Gynecologic oncology

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1198474

Publication Year

1987

PubMed ID

3653766

Publication Title

Edmonson JH, Krook JE, Hilton JF, Malkasian GD, Everson LK, Jefferies JA, Mailliard JA. Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma. Gynecol Oncol. 1987 Sep; 28(1):20-4.